GB202108608D0 - Preparation of a ph-adjusted ascorbic acid solution - Google Patents

Preparation of a ph-adjusted ascorbic acid solution

Info

Publication number
GB202108608D0
GB202108608D0 GBGB2108608.7A GB202108608A GB202108608D0 GB 202108608 D0 GB202108608 D0 GB 202108608D0 GB 202108608 A GB202108608 A GB 202108608A GB 202108608 D0 GB202108608 D0 GB 202108608D0
Authority
GB
United Kingdom
Prior art keywords
preparation
adjusted
acid solution
ascorbic acid
ascorbic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2108608.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Priority to GBGB2108608.7A priority Critical patent/GB202108608D0/en
Publication of GB202108608D0 publication Critical patent/GB202108608D0/en
Priority to EP22734289.6A priority patent/EP4355368A1/en
Priority to CN202280043073.1A priority patent/CN117500525A/zh
Priority to US18/569,177 priority patent/US20240350683A1/en
Priority to PCT/EP2022/066481 priority patent/WO2022263592A1/en
Priority to JP2023577510A priority patent/JP2024523884A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2108608.7A 2021-06-16 2021-06-16 Preparation of a ph-adjusted ascorbic acid solution Ceased GB202108608D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB2108608.7A GB202108608D0 (en) 2021-06-16 2021-06-16 Preparation of a ph-adjusted ascorbic acid solution
EP22734289.6A EP4355368A1 (en) 2021-06-16 2022-06-16 Preparation of a ph-adjusted ascorbic acid solution
CN202280043073.1A CN117500525A (zh) 2021-06-16 2022-06-16 pH调节的抗坏血酸溶液的制备
US18/569,177 US20240350683A1 (en) 2021-06-16 2022-06-16 Preparation of a ph-adjusted ascorbic acid solution
PCT/EP2022/066481 WO2022263592A1 (en) 2021-06-16 2022-06-16 Preparation of a ph-adjusted ascorbic acid solution
JP2023577510A JP2024523884A (ja) 2021-06-16 2022-06-16 pH調整されたアスコルビン酸溶液の調製

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2108608.7A GB202108608D0 (en) 2021-06-16 2021-06-16 Preparation of a ph-adjusted ascorbic acid solution

Publications (1)

Publication Number Publication Date
GB202108608D0 true GB202108608D0 (en) 2021-07-28

Family

ID=76954449

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2108608.7A Ceased GB202108608D0 (en) 2021-06-16 2021-06-16 Preparation of a ph-adjusted ascorbic acid solution

Country Status (6)

Country Link
US (1) US20240350683A1 (cg-RX-API-DMAC7.html)
EP (1) EP4355368A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024523884A (cg-RX-API-DMAC7.html)
CN (1) CN117500525A (cg-RX-API-DMAC7.html)
GB (1) GB202108608D0 (cg-RX-API-DMAC7.html)
WO (1) WO2022263592A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201915206D0 (en) 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007042781A2 (en) 2005-10-10 2007-04-19 Ge Healthcare Limited Automated method for preparing technetium complexes
WO2011097649A2 (en) 2010-02-08 2011-08-11 Lantheus Medical Imaging, Inc. Methods and apparatus for synthesizing imaging agents, and intermediates thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458396B (zh) * 2009-04-15 2017-05-10 兰休斯医疗成像公司 使用抗坏血酸稳定化放射性药物组合物
GB201915206D0 (en) * 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007042781A2 (en) 2005-10-10 2007-04-19 Ge Healthcare Limited Automated method for preparing technetium complexes
WO2011097649A2 (en) 2010-02-08 2011-08-11 Lantheus Medical Imaging, Inc. Methods and apparatus for synthesizing imaging agents, and intermediates thereof

Also Published As

Publication number Publication date
WO2022263592A1 (en) 2022-12-22
EP4355368A1 (en) 2024-04-24
JP2024523884A (ja) 2024-07-02
CN117500525A (zh) 2024-02-02
US20240350683A1 (en) 2024-10-24

Similar Documents

Publication Publication Date Title
SG10202012352XA (en) Triesters of cyclohexanetripropionic acid
ZA202107709B (en) Cell-free production of ribonucleic acid
IL236860A0 (en) Herbicidal preparations containing 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or its derivative and triazolopyrimidine sulfonamides
IL236856B (en) Herbicidal preparations containing 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or its derivative and glyphosate or glufosinate
IL232978B (en) Herbicidal composition containing 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or derivative thereof and fluroxypyr or derivatives thereof
GB202108607D0 (en) Preparation of a ph-adjusted ascorbic acid solution
PH12015500122A1 (en) Herbicidal compositions comprising 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl) pyridine-2-carboxylic acid or a derivative thereof and a sulfonylaminocarbonyltriazolinone
GB201901982D0 (en) Emulation of electrophysiological signals derived by stimulation of a body
GB2593902B (en) Salt of a pharmaceutical compound
IL260316A (en) A novel liquid formulation of long-acting human growth hormone conjugate
WO2012053849A3 (ko) 제모용 조성물
MX361275B (es) Formulacion de capsula de acido 5-aminosalicilico.
EP2794904A4 (en) AMPLIFICATION OF A SEQUENCE FROM A RIBONUCLEIC ACID
PT3592148T (pt) Utilização de ácido beta-ciclocítrico ou um seu sal para intensificar a tolerância de plantas a estresse devido a seca
GB202301180D0 (en) Salt of a pharmaceutical compound
ZA202201939B (en) Production of malic acid
IL286692A (en) Crystal form of acid addition salt of furopyrimidine compound
GB202108612D0 (en) Ascorbic acid vial
HUE064779T2 (hu) A tapentadol foszforsav sójának elnyújtott hatóanyag-leadást biztosító adagolási formája
GB202308485D0 (en) Preparation of a solution of polymer/nucleic acid complexes
EP3965771A4 (en) FINISHED PHARMACEUTICAL DOSAGE FORM OF A METHENAMINE SALT SUCH AS METHENAMINE MANDELATE
ZA202210103B (en) Preparation of a confectionery
IL234087A0 (en) The composition of an ascorbic acid derivative and a method for its production, a solution of an ascorbic acid derivative and an external preparation for the skin
EP4409048A4 (en) PREPARATION OF ALKALINE SALT SOLUTIONS
ZA202211102B (en) A preparation method of a palbociclib intermediate

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)